Experimental models on hemorragic shock;Modelos experimentales sobre shock hemorrágico

Nutricion Hospitalaria

Volumn 22, Issue 2, 2007, Pages 190-198

  Mauriz, José Luis ^a   Martin Renedo J ^a   Barrio, J P ^a   Culebras, J M ^b   Gonzalez P ^a  

^a UNIVERSITY OF LEÓN   (Spain)

^b Gerencia Regional de Salud de Castilla y León   (Spain)

Author keywords

Amino acid; Antioxidant; Hemorrhagic shock; Oxidative stress

Indexed keywords

AMINO ACID; ANTIOXIDANT; CYTOKINE; ENDOTOXIN; FREE RADICAL; LIPID;

HEMORRHAGIC SHOCK; HUMAN; HYPOVOLEMIA; MORTALITY; MULTIPLE ORGAN FAILURE; OXIDATIVE STRESS; OXYGEN DELIVERY DEVICE; PATHOGENESIS; REVIEW;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; SHOCK, HEMORRHAGIC;

EID: 34248638491     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Zhong Z, Enomoto N, Connor HD, Moss N, Mason RP, Thurman RG. Glycine improves survival after hemorrhagic shock in the rat. Shock 1999; 12: 54-62.
2. Wang P, Ayala A, Dean RE y cols. Adequate crystalloid resuscitation restores but fails to maintain the active hepatocellular function following hemorrhagic shock. J Trauma 1991; 31: 601-607.
3. Clemens MG, Bauer M, Gingalewski C, Miescher E, Zhang J. Hepatic intracellular communication in shock and inflammation. Shock 1994; 2: 1-9.
4. Gutiérrez G, Reines HD, Wulf-Gutiérrez ME. Clinical Review: hemorrhagic shock. Crit Care 2004; 8; 373-381.
5. Committee on Trauma: Advanced Trauma Life Support Manual. Chicago. American Collage of Surgeons 1997; 103-112.
6. Shenkar R, Coulson WF, Abraham E. Hemorrhage and resuscitation induce alterations in cytokine expression and the development of acute lung injury. Am J Respir Cell Mol Biol 1994; 10: 290-297.
7. Glantzounis GK, Slacinski HJ, Wenxuan Y, Davidson BR, Feifalina AM. The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: a review. Liver Transpl 2005; 9: 1031-1047.
8. Yamakawa Y, Takano M, Patel M, Tien N, Takada T, Bulkley GB. Interaction of platelet activating factor, reactive oxygen species generated by xanthine oxidase, and leukocytes in the generation of hepatic injury after shock/resuscitation. Ann Surg 2000; 231: 387-398.
9. Blum H, Osbakken MD, Johnson RG, Jr. Sodium flux and bioenergetics in the ischemic rat liver. Magn Reson Med 1991; 18: 384-357.
10. Farber JL. The role of calcium in cell death. Life Sci 1981; 29: 1289-1295.
11. Guillemin K, Krasnow MA. The hypoxic response: huffing and HIFing. Cell 1997; 89: 9-12.
12. Fondevila C, Busuttil RW, Kupiec-Weglinski JW. Hepatic ischemia/reperfusion injury-a fresh look. Exp Mol Pathol 2003; 74: 86-93.
13. Lentsch AB, Kato A, Yohidome H, McMasters KM, Edwards MJ. Inflamatory mechanisms and therapeutic strategies for warm epatic ischemia reperfusion injury. Hepatology 2000; 32: 169-173.
14. Liu TZ, Lee KT, Chern CL, Cheng JT, Stern A, Tsai LY. Free radical triggered hepatic injury of experimental obstructive jaundice of rats involves overproduction of porinflammatory cytokines and enhanced activation of nuclear factor kappab. Ann Clin Lab Sci 2001; 31: 383-390.
15. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells) Eur J Biochem 1990; 192: 245-261.
16. Caldwell-Kenkel JC, Currin RT, Tanaka Y, Thurman RG, Lemasters JJ. Kupffer cell activation and endothelial cell damage after storage of rat livers: effects of reperfusión. Hepatology 1991; 13: 83-95.
17. Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury. J Gastroenterol Hepatol. 2000; 15: 718-724.
18. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-376.
19. Granger DN, Kubes P: The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol 1994; 55: 662-675.
20. Rauen U, Polzar B, Stephan H, Mannherz HG, De Groot H. Cold-induced apoptosis in cultured hepatocytes and liver endothelial cells: mediation by reactive oxygen species. FASEB J 1999; 13: 155-168.
21. Mollen KP, Anand RJ, Tsung A, Prince JM, Levy RM, Billiar TR. Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage. Shock 2006; 26: 430-437.
22. 2+ regulation during hemorrhagic shock and resuscitation. Hepatology 1997; 25: 379-384.
23. Cheung JY, Bonventre JV, Malis CD, Leaf A. Calcium and ischemic injury. N Engl J Med 1986; 314 (26): 1670-1676.
24. Trump BF, Berezesky IK. Calcium-mediated cell injury and cell death. FASEB J 1995; 9: 219-228.
25. Colletti LM, Kunkel SL, Walz A y cols. The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology 1996; 23: 506-514.
26. Rose S, Sayeed. Superoxide radical scavenging prevents cellular calcium dysregulation during intraabdominal sepsis. 1: Shock 1997; 7: 263-268.
27. Burdette, WJ. Oxygen consumption of cardiac muscle during shock. Am J Physiol 1952; 168: 575-583.
28. Schwartz TB. Proteolytic activity and protein metabolism of rat diaphragm in hemorrhagic shock. Proc Soc Exptl Bio Med 1953. 83; 362-367.
29. Strawitz JG, Hift F, Temple RL, Ehrhardt A, Rozansky N. Irreversible hemorrhagic shock in rats: method and critical bleeding volume. Am J Physiol 1961; 200: 257-260.
30. Steinman R Denstedt OF. Experimental production of hemorrhagic shock in the rat. Can J Physiol Pharmacol 1969; 47: 305-310.
31. Wang G, Zhao M, Wang EH: Effects of glycine and methylprednisolone on hemorrhagic shock in rats. Chin Med J 2004; 117: 1334-1341.
32. Mauriz JL, Matilla B, Culebras JM, Gonzalez P, Gonzalez-Gallego J. Dietary glycine inhibits activation of nuclear factor kappa B and prevents liver injury in hemorrhagic shock in the rat. Free Radic Biol Med 2001; 31: 1236-1244.
33. Mauriz JL, González P, Jorquera F, Olcoz JL, González- Gallego J. Caspase inhibition does not protect against liver damage in hemorrhagic shock. Shock 2003; 19: 33-37.
34. Rothe CF. Heart failure and fluid loss in hemorrhagic shock. Fed Proc. 1970; 29: 1854-1860.
35. Epstein CJ, Avraham KB, Lovett M y cols. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc Natl Acad Sci SA 1987; 84: 8044-8048.
36. Duranski MR, Elrod JW, Calvert JW, Bryan NS, Feelisch M, Lefer DJ. Genetic overexpression of eNOS attenuates hepatic ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2006; 291: 2980-2986.
37. Selzner M, Rudiger HA, Selzner N, Thomas DW, Sindram D, Clavien PA. Transgenic mice overexpressing human Bcl-2 are resistant to hepatic ischemia and reperfusion. J Hepatol 2002; 36: 218-225.
38. Janssen H, Janssen PH, Broelsch CE. UW is superior to Celsior and HTK in the protection of human liver endothelial cells against preservation injury. Liver Transpl 2004; 10: 1514-1523.
39. Cao L, Li Y, Cheng F, Li S, Long D. Hypoxia/reoxygenation up-regulated the expression of death receptor 5 and enhanced apoptosis in human hepatocyte line. 1: Transplant Proc 2006; 38: 2207-2209.
40. Wang X, Wang Y, Zhang J, Kim HP, Ryter SW, Choi AM. FLIP protects against hypoxia/reoxygenation-induced endothelial cell apoptosis by inhibiting Bax activation. Mol Cell Biol 2005; 25: 4742-4751.
41. Brigelius-Flohe R, Kelly FJ, Salonen JT, Neuzil J, Zingg JM, Azzi A. The European perspective on vitamin E: current knowledge and future research. Am J Clin Nutr 2002; 76: 703-716.
42. Calfee-Mason KG, Spear BT, Glauert HP. Vitamin E inhibits hepatic NF-kappaB activation in rats administered the hepatic tumor promoter, phenobarbital. J Nutr 2002; 132: 3178-3185.
43. Masaki H, Okano Y, Ochiai Y, Obayashi K, Akamatsu H, Sakurai H. alpha-tocopherol increases the intracellular glutathione level in HaCaT keratinocytes. Free Radic Res 2002; 36: 705-709.
44. th anniversary of vitamin E: Beyond its antioxidant properties. Biol Chem 2002; 383: 457-465.
45. Marubayashi S, Dohi K, Yamada K, Kawasaki T. Changes in the levels of endogenous coenzyme Q homologs, alpha-tocopherol, and glutathione in rat liver after hepatic ischemia and reperfusion, and the effect of pretreatment with coenzyme Q10. Biochim Biophys Acta 1984; 797: 1-9.
46. Giakoustidis D, Papageorgiou G, Iliadis S y cols. Intramuscular administration of very high dose of alpha-tocopherol protects liver from severe ischemia/reperfusion injury. World J Surg 2002; 26: 872-877.
47. Eum HA, Lee SH, Lee SM. Trolox C ameliorates hepatic drug metabolizing dysfunction after ischemia/reperfusion. Arch Pharm Res 2002; 25: 940-945.
48. Vardareli E, Saricam T, Koken T, Degirmenci I, Aral E, Erenoglu E. The effect of alpha-tocopherol and pentoxyfilline on ischemia-reperfusion induced liver injury in rats. Hepatogastroenterology 1998; 45: 1505-1508.
49. Seo MY, Lee SM. Protective effect of low dose of ascorbic acid on hepatobiliary function in hepatic ischemia/reperfusion in rats. J Hepatol 2002; 36: 72-77.
50. Cerwenka H, Khoschsorur G, Bacher H y cols. Normothermic liver ischemia and antioxidant treatment during hepatic resections. Free Radic Res 1999; 30: 463-469.
51. Genova ML, Bonacorsi E, D'Aurelio M y cols. Protective effect of exogenous coenzyme Q in rats subjected to partial hepatic ischemia and reperfusion. Biofactors 1999; 9: 345-349.
52. Schutz E, Wieland E, Hensel A y cols. Suppression of leukocyte-enhanced cold ischemia/reperfusion injury of liver endothelium with the benzoquinone antioxidant idebenone. Clin Biochem 1997; 30: 619-624.
53. Rodríguez-Reynoso S, Leal C, Portilla E, Olivares N, Muniz J. Effect of exogenous melatonin on hepatic energetic status during ischemia/reperfusion: possible role of tumor necrosis factor-alpha and nitric oxide. J Surg Res 2001; 100: 141-149.
54. Chen JC, Ng CJ, Chiu TF, Chen HM. Altered neutrophil apoptosis activity is reversed by melatonin in liver ischemia-reperfusion. J Pineal Res 2003; 34: 260-264.
55. Martínez-Flórez S, González-Gallego J, Culebras JM, Tuñón MJ. Flavonoides: propiedades y acción antioxidante. Nutr Hosp 2002; 17: 271-278.
56. Schauer RJ, Kalmuk S, Gerbes AL y cols. Intravenous administration of glutathione protects parenchymal and non-parenchymal liver cells against reperfusion injury following rat liver transplantation. World J Gastroenterol 2004; 10: 864-870.
57. Schauer RJ, Gerbes AL, Vonier D y cols. Glutathione protects the rat liver against reperfusion injury after prolonged warm ischemia. Ann Surg 2004; 239: 220-231.
58. Boman G, Backer U, Larsson S, Melander B, Wahlander L. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases. Eur J Respir Dis 1983; 64: 405-415.
59. Amersi F, Nelson SK, Shen XD y cols. Bucillamine, a thiol antioxidant, prevents transplantation-associated reperfusion injury. Proc Natl Acad Sci USA 2002; 99: 8915-8920.
60. Nguyen WD, Kim DH, Alam HB, Provido HS, Kirkpatrick JR. Polyethylene glycol-superoxide dismutase inhibits lipid peroxidation in hepatic ischemia/reperfusion injury. Crit Care 1999; 3: 127-130. Links
61. Nordstrom G, Saljo A, Hasselgren PO. Studies on the possible role of oxygen-derived free radicals for impairment of protein and energy metabolism in liver ischemia. Circ Shock 1988; 26: 115-126.
62. Tanaka J, Malchesky PS, Omokawa S y cols. Effects of prostaglandin I2, superoxide dismutase, and catalase on ischemiareperfusion injury in liver transplantation. ASAIO Trans 1990; 36: M600-M603.
63. Yabe Y, Koyama Y, Nishikawa M, Takakura Y, Hashida M. Hepatocyte-specific distribution of catalase and its inhibitory effect on hepatic ischemia/reperfusion injury in mice. Free Radic Res 1999; 30: 265-274.
64. Lehmann TG, Wheeler MD, Schoonhoven R, Bunzendahl H, Samulski RJ, Thurman RG. Delivery of Cu/Zn-superoxide dismutase genes with a viral vector minimizes liver injury and improves survival after liver transplantation in the rat. Transplantation 2000; 69: 1051-1057.
65. Lehmann TG, Wheeler MD, Froh M y cols. Effects of three superoxide dismutase genes delivered with an adenovirus on graft function after transplantation of fatty livers in the rat. Transplantation 2003; 76: 28-37.
66. Zwacka RM, Zhou W, Zhang Y y cols. Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kappaB activation. Nat Med 1998; 4: 698-704.
67. Pérez de la Cruz AJ, Abilés J, Pérez Abud R. Perspectives in the design and development of new products for enteral nutrition. Nutr Hosp 2006; 21 (Supl. 2): 98-108.
68. Grau Carmona T, Bonet Saris A, Fernández Ortega F. Artificial nutrition in intestinal failure: short bowel syndrome. Inflammatory Bowel Disease. Nutr Hosp 2005; 20 (Supl. 2): 31-33.
69. Kanth VR, Reddy PU, Raju TN. Behavioral, morphological and physiological shift in the rats administered with tryptophan deficient regimen. Nutr Hosp 2006; 21: 596-603.
70. Bulbuller N, Pektas B, Ozdarendeli A, Dogru O, Aygen E, Akpolat N. The effect of L-tryptophan on hemorrhagic shock induced bacterial translocation. J Surg Res 2005; 123: 194-199.
71. Konturek SJ, Konturek PC, Brzozowski T. Melatonin in gastroprotection against stress-induced acute gastric lesions and in healing of chronic gastric ulcers. J Physiol Pharmacol 2006; 57 (Supl. 5): 51-66.
72. Dhar A, Kujath S, Van Way CW. Glutamine administration during total parenteral nutrition protects liver adenosine nucleotides during and after subsequent hemorrhagic shock. J Parenter Enteral Nutr 2003; 27: 246-251.
73. Van Way CW, Dhar A, Morrison D. Hemorrahagic shock: a new look at an old problem. Mo Med 2003; 100: 518-523.
74. Schroder J, Kahlke V, Fandrich F y cols. Glutamine dipeptides- supplemented parenteral nutrition reverses gut mucosal structure and interleukin-6 release of rat intestinal mononuclear cells after hemorrhagic shock. Shock 1998; 10: 26-31.
75. Fontana Gallego L, Sáez Lara MJ, Santisteban Bailón R, Gil Hernández A. Nitrogenous compounds of interest in clinical nutrition. Nutr Hosp 2006; 21 (Supl. 2): 14-27.
76. Yang R, Tan X, Thomas AM y cols. Alanine-Glutamine Dipeptide (AGD) Inhibits Expression of Inflammation-Related Genes in Hemorrhagic Shock. J Parenter Enteral Nutr 2007; 31: 32-36.
77. Matilla B, Mauriz JL, Culebras JM, González-Gallego J, González P. Glycine: a cell-protecting anti-oxidant nutrient. Nutr Hosp 2002; 17: 2-9.
78. Wang G, Wang EH: The effect of glycine on survival after hemorrhagic shock in the rats. Zhonghua Wai Ke Za Zhi 2004; 42: 296-301.
79. Wang G, Wang Y, Guan FL, Ren GC, Wang YZ. The effect of combination of glycine and methylprednisolone on Kupffer cells of liver after hemorrhagic shock in rats. Zhonghua Wai Ke Za Zhi 2006; 44: 349-352.
80. Bemelmans MH, Greve JW, Gouma DJ, Buurman WA. Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; soluble TNF receptors as prognostic factors for mortality. Gut 1996; 38: 447-453.
81. Jiang J, Bahrami S, Leichtfried G y cols. Kinetics of endotoxin and tumor necrosis factor appearance in portal and systemic circulation after hemorrhagic shock in rats. Ann Surg 1995, 221: 100-106.
82. Sheen-Chen SM, Chen HS, Ho HT, Chen WJ, Sheen CC, Eng HL. Effect of bile acid replacement on endotoxin-induced tumor necrosis factor-alpha production in obstructive jaundice. World J Surg 2002; 26: 448-450.
83. Bertok L. Effect of bile acids on endotoxin in vitro and in vivo (physico-chemical defense) Bile deficiency and endotoxin translocation. Ann N Y Acad Sci 1998; 851: 408-410.
84. Vreugdenhil AC, Rousseau CH, Hartung T, Greve JW, Van't Veer C, Buurman WA. Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons. J Immunol 2003; 170: 1399-1405.
85. Harris HW, Grunfeld C, Feingold KR y cols. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest 1993; 91: 1028-1034.
86. Rauchhaus M, Coats AJ, Anker SD. The endotoxin-lipoprotein hypothesis. Lancet 2000; 356: 930-933.
87. Vreugdenhil AC, Snoek AM, Van't Veer C y cols. LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction. J Clin Invest 2001; 107: 225-234.
88. Luyer MD, Buurman WA, Hadfoune M y cols. Pretreatment with high fat enteral nutrition reduces endotoxin and tumor necrosis factor alpha and preserves gut barrier function early after hemorrhagic shock. Shock 2004; 21: 65-71.
89. Luyer MD, Buurman WA, Hadfoune M, Jacobs JA, Dejong CH, Greve JW. High-fat enteral nutrition reduces endotoxin, tumor necrosis factor-alpha and gut permeability in bile duct-ligated rats subjected to hemorrhagic shock. J Hepatol 2004, 41: 377-383.
90. Luyer MD, Jacobs JA, Vreugdenhil AC y cols. Enteral administration of high-fat nutrition before and directly after hemorrhagic shock reduces endotoxemia and bacterial translocation. Ann Surg 2004; 239: 257-264.